Submitted by Anonymous (not verified) on 21 August 2026 - 13:55
Orphan designation: setanaxib Treatment of Alport syndrome, 08/11/2023 Positive
Source:
Orphan designation: setanaxib Treatment of Alport syndrome, 08/11/2023 Positive